551,293 Shares in Ardent Health, Inc. $ARDT Bought by Empowered Funds LLC

Empowered Funds LLC purchased a new position in shares of Ardent Health, Inc. (NYSE:ARDT) during the 2nd quarter, Holdings Channel.com reports. The fund purchased 551,293 shares of the company’s stock, valued at approximately $5,425,000.

A number of other large investors have also recently added to or reduced their stakes in the company. Caitong International Asset Management Co. Ltd grew its position in shares of Ardent Health by 1,177.7% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 2,862 shares of the company’s stock valued at $25,000 after acquiring an additional 2,638 shares during the period. Allworth Financial LP acquired a new position in shares of Ardent Health during the 2nd quarter worth about $28,000. Zurcher Kantonalbank Zurich Cantonalbank bought a new stake in shares of Ardent Health in the 3rd quarter valued at about $61,000. Monetary Solutions Ltd bought a new stake in shares of Ardent Health in the 4th quarter valued at about $79,000. Finally, New York State Common Retirement Fund lifted its stake in Ardent Health by 121.4% in the 2nd quarter. New York State Common Retirement Fund now owns 6,200 shares of the company’s stock valued at $85,000 after purchasing an additional 3,400 shares during the last quarter.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on ARDT shares. Wall Street Zen cut Ardent Health from a “buy” rating to a “hold” rating in a report on Sunday, July 12th. Guggenheim upped their price objective on Ardent Health from $13.00 to $14.00 and gave the company a “buy” rating in a research note on Thursday, August 6th. UBS Group raised their price objective on Ardent Health from $13.00 to $13.50 and gave the company a “buy” rating in a research report on Thursday, May 7th. Truist Financial lifted their target price on Ardent Health from $12.00 to $13.00 and gave the stock a “buy” rating in a research note on Thursday, August 6th. Finally, Weiss Ratings lowered Ardent Health from a “sell (d+)” rating to a “sell (d)” rating in a report on Tuesday, August 11th. Seven investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $13.05.

Ardent Health Price Performance

Shares of ARDT opened at $10.85 on Tuesday. The company’s 50-day moving average is $10.59 and its 200-day moving average is $9.78. The company has a debt-to-equity ratio of 0.61, a current ratio of 2.10 and a quick ratio of 1.99. The firm has a market capitalization of $1.53 billion, a PE ratio of 19.73, a PEG ratio of 3.07 and a beta of 0.70. Ardent Health, Inc. has a fifty-two week low of $7.71 and a fifty-two week high of $15.48.

Ardent Health (NYSE:ARDT) last announced its earnings results on Tuesday, August 4th. The company reported $0.12 EPS for the quarter, missing the consensus estimate of $0.18 by ($0.06). Ardent Health had a return on equity of 10.35% and a net margin of 1.22%.The company had revenue of $1.62 billion for the quarter, compared to the consensus estimate of $1.59 billion. Ardent Health has set its FY 2026 guidance at 0.780-1.150 EPS. Equities analysts forecast that Ardent Health, Inc. will post 0.97 EPS for the current year.

Insider Transactions at Ardent Health

In other news, CFO Alfred Lumsdaine acquired 10,000 shares of Ardent Health stock in a transaction dated Friday, June 5th. The stock was bought at an average price of $8.81 per share, for a total transaction of $88,100.00. Following the completion of the acquisition, the chief financial officer directly owned 329,183 shares in the company, valued at approximately $2,900,102.23. The trade was a 3.13% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 1.90% of the stock is owned by company insiders.

About Ardent Health

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.